Rose E. Sekulovich
Arcturus Therapeutics (United States)(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Virus-based gene therapy research, Cytomegalovirus and herpesvirus research
Most-Cited Works
- → Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection(1999)485 cited
- → A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant(1999)248 cited
- → Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes(1994)206 cited
- → The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0(1988)188 cited
- → Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial(1997)168 cited
- → Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine(1999)106 cited
- → Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens(1992)101 cited
- → The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule(1989)82 cited
- → Limited Antibody‐Dependent Cellular Cytotoxicity Antibody Response Induced by a Herpes Simplex Virus Type 2 Subunit Vaccine(2000)69 cited
- → Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials(2024)69 cited